Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

General

‘RUMOR: Samsung is exploring the idea of using Qualcomm’s new Oryon cores (by Nuvia) for their Mixed Reality competitor’ -Tweet From Brad Lynch

https://twitter.com/SadlyItsBradley/status/1626233199243448322

byBill Haddad

February 16, 2023

1 minute read

RUMOR: Samsung is exploring the idea of using Qualcomm’s new Oryon cores (by Nuvia) for their Mixed Reality competitor

If true, this could be the way that the Korean giant hopes to compete with the Apple MR HMD which is rumored to use a M2 chip for processing https://t.co/okHmNIoMmV

— Brad Lynch (@SadlyItsBradley) February 16, 2023

Hallmark Parent Crown Media’s CEO Departs Month After Same-Sex Ad Controversy

By Neer Varshney

Today, 6:20 AM

The President and CEO of Hallmark Channel’s parent Crown Media Holdings Inc., Bill Abbott, is leaving the company,…

NFLX

Wingstop Stock Jumps On Solid Q3, Raised FY22 EPS Outlook

By Shivani Kumaresan

Today, 6:20 AM

Wingstop In (NASDAQ:WING) reported third-quarter FY22 sales growth of 40.9% year-on-year to $92.67 million, beating the consensus of $89.46 million. System-wide…

WING

Catalyst Biosciences Stock More Than Doubles After Assets Sale To Vertex

By Vandana Singh

Today, 6:20 AM

Catalyst Biosciences Inc (NASDAQ:CBIO) has agreed to sell its portfolio of protease medicines that regulate complement to Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) for $60…

BIIB

ChemoCentryx Stock Jumps On Amendment In Avacopan Application, New Goal Date Of October 7

By Vandana Singh

Today, 6:20 AM

Following consultations with the FDA, ChemoCentryx Inc (NASDAQ:CCXI) filed an amendment to its marketing application seeking approval for avacopan to treat Anti-neutrophil…

CCXI

‘RUMOR: Samsung is exploring the idea of using Qualcomm’s new Oryon cores (by Nuvia) for their Mixed Reality competitor’ -Tweet From Brad Lynch

Related Posts

Hallmark Parent Crown Media’s CEO Departs Month After Same-Sex Ad Controversy

Wingstop Stock Jumps On Solid Q3, Raised FY22 EPS Outlook

Catalyst Biosciences Stock More Than Doubles After Assets Sale To Vertex

ChemoCentryx Stock Jumps On Amendment In Avacopan Application, New Goal Date Of October 7